ABVC BioPharma, Inc. (ABVC) NASDAQ
1.25
-0.11(-8.09%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.25
-0.11(-8.09%)
Currency In USD
| Market Cap | 49.54M |
| Enterprise Value | 52.33M |
| P/E Ratio | -3.38 |
| PEG Ratio | 0.15 |
| Price/Sales Ratio | -22.76 |
| Price/Book Ratio | 2.95 |
| Enterprise/Revenue | -26.01 |
| Enterprise/EBITDA | -2.26 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 11.84 |
| Operating Margin | 11.09 |
| Return On Assets | -0.48 |
| Return On Equity | -0.92 |
| Revenue | 0 |
| Revenue/Share | -0.03 |
| Gross Profit | 0 |
| EBITDA | -7.43M |
| Net Income | -7.91M |
| Diluted EPS | -0.39 |
| Total Cash | 202,509 |
| Total Cash/Share | 0.01 |
| Total Debt | 2.73M |
| Total Debt/Equity | 0.25 |
| Current Ratio | 0.12 |
| Book Value Per Share | 0.5 |
| 52-Week Change | -18.83 |
| 52-Week High | 5.48 |
| 52-Week Low | 0.88 |
| Moving Average 50 Days | 1.17 |
| Moving Average 200 Days | 2.1 |
| Average Volume | 102,222 |
| Shares Outstanding | 14.49M |
| % Held by Institutions | 1.78 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | July 25, 2023 |